org placeholder image

Matthew Defrese

Cmc Manager at Oncovir

  • LinkedIn

Email Email: m****@oncovir.com

phone noPhone Number: (***)-***-****

I am the CEO and Co-Founder of Cyrus Scientific, a pharmaceutical consulting firm and GLP laboratory consisting of a team of pharmaceutical professionals with extensive expertise in a ran...

Read More

map
ONCOVIR

ONCOVIR

  • Headquarter Headquarters: 3203 Cleveland Ave Nw, Washington, District Of Columbia, 20008, United States
  • Industry Industry Pharmaceuticals
  • website Website oncovir.com
  • description Description
    Oncovir, Inc is a pharmaceutical corporation dedicated to the development of nucleic-acid-based clinical therapies for cancer, infectious, immune, and degenerative disorders. We promote Hilto...

    Read More

  • Employees count Employees 1-10
  • Revenue Revenue Under 1 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Oncovir Org Chart and Mapping

Employees

Frequently Asked Questions Regarding Matthew Defrese

Answer: Matthew Defrese works for Oncovir as Cmc Manager

Answer: Matthew Defrese’s role in Oncovir is Cmc Manager

Answer: Matthew Defrese's email address is m***@gmail.com

Answer: Matthew Defrese's business email address is m****@oncovir.com

Answer: Matthew Defrese’s direct phone number is (***)-***-****

Answer: Matthew Defrese works in the industry of: Pharmaceuticals

Answer: Matthew Defrese is the current Cmc Manager at Oncovir.... Read More

Answer: Matthew Defrese works Oncovir located at 3203 Cleveland Ave Nw, , District of Columbia, Washington, 20008, United States

Answer: Oncovir's Cmc Manager is Matthew Defrese

Answer: Matthew Defrese contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@oncovir.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access